These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-004464-69 A Home Based Phase IIb, Multi-centre, Randomised, Double-Blind, Placebo Controlled, Dose Finding Parallel Group Study to explore the Optimal Dose of Inhaled VR004 in Patients with Erectile Dysfunction... 2006-05-03 due-trials
Reported results 2005-004065-42 Phase II, double blind, intermittent dose, placebo controlled, randomised, two period crossover study to investigate the effect of inhaled doses of VR776 administered via Aspirair inhaler on IVELT (in... 2007-03-15 due-trials
Reported results 2005-005120-13 A clinic based, Phase IIa, randomised, double-blind, placebo-controlled, ascending dose, single centre study investigating the safety, tolerability, efficacy, and pharmacokinetics of VR040 in patients... 2006-05-31 due-trials
Completed, but no date, and reported results 2005-005476-32 A Phase IIb, Randomised, Double-Blind, Placebo Controlled, Dose Finding Study Assessing the Haemodynamic Safety and "At Home" Efficacy of Inhaled VR004 in patients with Erectile Dysfunction (ED). bad-data
Not reported 2006-004582-33 A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalating Study Investigating the Efficacy and Safety of VR040 in the Treatment of Unpredictable “Off” or End-of-Dose “Wearing Off... 2006-11-03 due-trials
Reported results 2006-005509-79 A Clinic-Based, Phase IIa, Randomised, Double-Blind, Placebo-Controlled, Ascending-Dose, Multicentre Study Investigating the Safety, Tolerability, Efficacy, and Pharmacokinetics of VR040 in Patients w... 2007-08-29 due-trials
Reported results 2007-006276-11 A Phase I/II randomised, placebo-controlled, double blind trial to assess the safety, tolerability, pharmacodynamics and exploratory efficacy of heparin 25 mg inhalation powder in patients with Cyst... 2010-10-25 due-trials
Reported results 2008-004447-11 A Phase IIb Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy and Safety of Apomorphine Inhalation Powder in Patients With “On-Off” or “Wearing-Off” Effe... 2010-07-15 due-trials
Reported results 2011-001772-19 A randomised, double-blind, placebo controlled, parallel group, study to evaluate the efficacy and safety of VR506 inhalation powder from a new dry powder inhaler in adolescent and adult subjects with... 2013-05-09 due-trials
Reported results 2011-005030-19 A randomised double-blind, parallel group, dose-ranging study to evaluate the efficacy and safety of three different total daily doses of fluticasone propionate inhaled from a new dry powder inhaler i... 2013-10-31 due-trials
Reported results Terminated 2012-004072-19 A randomized, double-blind, parallel group, placebo controlled Phase II study to evaluate the safety and efficacy of inhaled LASAG and Placebo, applied three times daily in adult hospitalized patients... 2015-05-06 due-trials
Trial is partly outside EEC, and reported results 2015-000353-20 A randomised, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two doses of nebulised budesonide delivered by the VR475 Inhalation System, with an open-lab... 2018-09-27 bad-data